To,
The Members,
Centuple Global Limited
(Formerly known as Checkpoint Trends Limited)
Your directors have pleasure in presenting Annual Report together with the Audited Accounts of the Company for the year ended 31 st March, 2026.
1. FINANCIAL RESULTS
Your Company financial performance during the year 2025-26 is summarized below:
(Rs. In Lakhs)
| Particulars | 2025-26 | 2024-25 |
| Income from Operations | 57,380.92 | 50.00 |
| Other Income | 0.17 | 0.12 |
| Total Income | 57,381.09 | 50.12 |
| Less: Expenses | 57,152.88 | 45.38 |
| Profit/(Loss) Before Extraordinary Items and | 228.21 | 4.74 |
| Tax | ||
| Less: Extraordinary Items | - | - |
| Less: Exceptional Items | - | - |
| Profit/(Loss) Before Tax | 228.21 | 4.74 |
| Less: Current Tax | 77.54 | 1.47 |
| Less: Deferred Tax | (0.06) | 0.73 |
| Profit/(Loss) After Tax | 150.72 | 2.54 |
| EPS (in Rs.) | 2.76 | 0.05 |
2. FINANCIAL SUMMARY
The Company earned income from operation of Rs. 57,380.92 (In Lakhs) during the FY 2025-26, as compared to the income from operation of Rs. 50.00 (In lakhs) earned in the previous FY 2024-25. The Companys Net Profit for the Financial Year ended March 31, 2026 stood at Rs. 150.72 (In Lakhs) as against a Net Profit of Rs. 2.54 (In Lakhs) in the previous year.
3. CHANGE IN NAME OF THE COMPANY
During the financial year under review, the name of the Company was changed from Checkpoint Trends Limited to Centuple Global Limited in the Meeting of Members through Postal Ballot dated Saturday, January 17, 2026.
The Fresh Certificate of Incorporation issued by the Registrar of Companies dated February 3, 2026.
1
4. CHANGE IN NATURE OF BUSINESS
During the financial year under review, there is no change in the nature of business of the Company.
The Company has filed the Waiver Application in the Financial Year 2025-26.
5. CHANGE IN THE OBJECT OF THE COMPANY
During the year under, there was change in the object of the company.
The Company and the Board in view to diversify and explore new business opportunities, proposed to amend the Object Clause to broaden its scope of activities and expand into new areas of business which align with and are complementary to its existing operations. The amendment empowers the Company to respond more effectively to emerging market opportunities, improve competitiveness, and create sustainable value for its stakeholders.
Thus, the Main Object Clause 3(A), 3(B), 3(C) of the Memorandum of Association was substituted with new clauses 3(A), 3(B) by way of (01/2025-26) Postal ballot dated May 19, 2025 in accordance with applicable provisions of the Companies Act, 2013.
Further, the existing Main Object Clause 3(A) and 3(B) be re-numbered as 3A(i) and 3A(ii) and new additional main object be numbered as 3A(iii) of the Memorandum of Association was amended by way of (02/2025-26) Postal ballot dated September 20, 2025 in accordance with applicable provisions of the Companies Act, 2013.
6. SHIFTING OF THE REGISTERED OFFICE OF THE COMPANY
During the financial year under review, there is change in the registered office of the Company.
The company through its (01/2025-26) postal ballot dated May 19, 2025 and in compliance with the provisions of Section 12 and other applicable provisions of the Companies Act, 2013, passed special resolution for shifting of the registered office of the company within the same state from 604, 6th floor, Meghdoot, Gulmohar Cross Road No. 6, JVPD Scheme, Mumbai - 400049 to Office No. 306, Shreenath Enclave Sr No.609/1Part, Plot No. 6 7 8, Shreehari Kute Marg Nr Samdeep Hotel, Mumbai Naka, Tidke Colony, Nashik 422002.
The shifting has been made to improve operational efficiency, administrative convenience, and access to better infrastructure and connectivity.
7. WEB LINK OF ANNUAL RETURN
The Annual Return for FY 2025-26 as required under Section 92(3) of the Act read with The Companies (Management and Administration) Rules, 2014 is available at https://www.rubramed.com
8. TRANSFER TO RESERVES
No amount has been transferred to Reserves during the year under review.
9. CHANGES IN SHARE CAPITAL
During the year under review, there was change in the Share Capital of the Company. The following changes are made:-
1. The company through its (01/2025-26) postal ballot dated May 19, 2025 for F.Y. 2025-26 increased its authorized share capital from the existing Rs. 8,20,00,000/- (Rupees Eight Crore and Twenty Lakhs only) divided into 82,00,000 (Eighty-Two Lakhs) equity shares of Rs.10/- (Rupees Ten) each to Rs. 75,00,00,000/- (Rupees Seventy-Five Crores only) divided into 7,50,00,000 (Seven Crores and Fifty Lakhs) equity shares of Rs. 10/- (Rupees Ten) each.
Pursuant to the above, Clause V of the Memorandum of Association and Clause 3 of the Articles of Association of the Company were amended through the (01/2025- 26) postal ballot dated May 19, 2025, in accordance with the applicable provisions of the Companies Act, 2013.
2. Further, the company through its (02/2025-26) postal ballot dated September 20, 2025 for F.Y. 2025-26 increased its authorized share capital from Rs. 75,00,00,000/- (Rupees Seventy-Five Crores only) divided into 7,50,00,000 (Seven Crores and Fifty Lakhs) equity shares of Rs. 10/- (Rupees Ten) each to Rs. 3,00,00,00,000/- (Rupees Three Hundred Crores) divided into 30,00,00,000 (Thirty Crores) equity shares of Rs. 10/- (Rupees Ten) each.
Pursuant to the above, Clause V of the Memorandum of Association and Clause 3 of the Articles of Association of the Company were amended through the (02/2025- 26) postal ballot dated September 20, 2025, in accordance with the applicable provisions of the Companies Act, 2013.
3. Further, the company through its (05/2025-26) postal ballot dated January 17, 2026 for F.Y. 2025-26 has increases in its authorized share capital from Rs. 3,00,00,00,000/- (Rupees Three Hundred Crores) divided into 30,00,00,000 (Thirty Crores) equity shares of Rs. 10/- (Rupees Ten) each to Rs. 7,50,00,00,000/- (Rupees Seven Hundred and Fifty Crores) divided into 75,00,00,000 (Seventy-Five Crores) equity shares of Rs. 10/- (Rupees Ten) each.
Pursuant to the above, Clause V of the Memorandum of Association and Clause 3 of the Articles of Association of the Company were amended through the (05/2025-26) postal ballot dated January 17, 2026, in accordance with the applicable provisions of the Companies Act, 2013.
4. However, currently the Authorized Share Capital of the Company stands at Rs. 7,50,00,00,000/- and the Paid-Up Share Capital of the Company stands at Rs. 5,46,83,000/-.
The number of convertible warrants 1,66,74,072 on a preferential basis issued in the Extra Ordinary General Meeting dated October 27, 2025.
10. DIVIDEND
The Board of Directors expressed their inability to recommend any dividend on equity shares for the year ended March 31, 2026.
11. PUBLIC DEPOSITS
During the year, the Company has not accepted any deposits from public nor during the previous financial year.
12. BUY-BACK / SWEAT EQUITY / BONUS SHARES
The Company has neither bought back its shares nor has issued any sweat equity or Bonus shares during the year under review.
13. EMPLOYEES STOCK OPTION PLAN
The Company has not provided any Stock Option Scheme to the Employees.
14. ISSUE OF DEBENTURES, BONDS OR ANY NON-CONVERTIBLE SECURITIES
The Company has not issued any debenture, bonds or non-convertible securities.
15. STATUTORY AUDITORS
M/s. L K Ajmera & Associates Chartered Accountants resigned as Statutory Auditors of the company with effect from the August 14, 2026, due to pre-occupation.
The New Statutory Auditor is yet to be appointed
16. INTERNAL AUDITOR
In the Board Meeting held on August 30, 2023, the Board appointed Mr. Arun Mulya as the Internal Auditor for a period of three years from FY 2023-2024 to FY 2025-2026.
Mr. Arun Mulya is the Internal Auditor of the Company for the FY 2025-26.
17. STATUTORY AUDIT REPORT
The Auditors Report on the financial statement for the current year is self-explanatory, therefore does not require any further explanation. The Company has already submitted declaration pursuant to Regulation 33(3)(d) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 to the Stock Exchange(s).
18. COST AUDITOR REPORT AND COST RECORD
Appointment of Cost Auditor and maintenance of cost records is not applicable to the company.
19. SECRETARIAL AUDITOR AND SECRETARIAL AUDIT REPORT
M/s. MNB & Co. LLP, Practising Company Secretaries, ceased to be the Secretarial Auditors of the Company with effect from August 28, 2025, due to pre-occupation.
Further, at the Extra Ordinary General Meeting of the members of the company M/S. Payal Dhamecha & Associates, Company Secretaries appointment as the Secretarial Auditor of the Company for a period of 5 years from the financial year 2025-26 to financial year 2029-30 to conduct the secretarial audit as prescribed under the Companies Act, 2013, at such remuneration as may be decided by the Board of Directors in consultation with the Secretarial Auditor.
The SEBI has amended the Listing Regulations with effect from December 12, 2024 by way of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) (Third Amendment) Regulations 2024 (SEBI Notification) on the Secretarial Audit and provides that every Listed Entity and its Material Unlisted Subsidiary incorporated in India shall undertake Secretarial Audit by a Secretarial Auditor who shall be a Peer-reviewed Company Secretary and shall be recommended by the Board for the approval of the Shareholders. The appointment of an individual as Secretarial Auditor shall not be more than one term of five consecutive years or a Secretarial Audit firm as Secretarial Auditor for not more than two terms of five consecutive years each with the approval of the Shareholders in the Annual General Meeting.
In line with the above SEBI amendment, the member appoint M/s. Payal Dhamecha & Associates, Company Secretaries as Secretarial Auditors of the Company for a period of five consecutive financial years i.e., from FY 2025-26 to FY 2029-30 on such terms of remuneration, including reimbursement of out-of-pocket expenses, as may be mutually agreed between the Board of Directors of the Company and the Secretarial Auditor.
In connection with the proposed appointment, M/s. Payal Dhamecha & Associates, Company Secretaries have confirmed their eligibility and independence to conduct the Secretarial Audit of Centuple Global Limited.
The Secretarial Audit Report for the Financial Year 2025-26 forms part of the Annual Report and attached herewith as Annexure- X.
The Secretarial Audit report for the current year is self-explanatory, therefore does not require any further explanation and listing fees has not paid due to financial crises faced by the company.
20. DETAILS IN RESPECT OF FRAUDS REPORTED BY AUDITORS UNDER SUB-SECTION (12) OF SECTION 143 OF THE COMPANIES ACT, 2013
There are no frauds reported by the Statutory Auditors of the Company under Section 143 (12) of the Companies Act, 2013.
21. DIRECTORS AND KEY MANAGERIAL PERSONNEL
In accordance with the Companies Act, none of the Directors are liable to retire by rotation at the ensuing Annual General Meeting.
Details of Composition of Board and KMPs as on March 31, 2026 are given below:-
| Sr. No. | Name of the Director | Category | Date of Appointment | Directorship in Other Companies # | Membership of Committee* | Member as Chairman of Committee |
| 1. | Mr. Shubham Chaudhary | Whole time Director | 06/03/2025 | 1 | 0 | 0 |
| 2. | Mr. Gunjan Gangwal | NonExecutive - Independent Director | 17/12/2025 | 1 | 2 | 0 |
| 3. | Mr. Kumar Anubhav Upadhyay | Whole time Director | 03/12/2025 | 1 | 0 | 0 |
| 4. | Ms. Shruti Gupta | Non Executive Independent Director | 04/04/2025 | 5 | 4 | 1 |
| 5. | Mr. Gaurav Kaushik | NonExecutive - Independent Director | 18/03/2026 | 0 | 2 | 0 |
| 6. | Mr. Ashish Jain | NonExecutive - Independent Director | 18/03/2026 | 0 | 2 | 0 |
| 7. | Ms. Artee Sahu | Company Secretary | 16/09/2024 | 0 | 0 | 0 |
During the year under review, the following changes were made in the composition of board of Directors:-
1. Following changes were made to the composition of the Board of Directors through a (01/2025-26) postal ballot dated May 19, 2025: -
Mr. Pradeep Kumar (DIN: 00209355), Whole Time Director is associated with a company undergoing Corporate Insolvency Resolution Process (CIRP) namely: -
Alpha Pecific Engineers Private Limited
2. Mr. Pradeep Kumar (DIN: 00209355) was appointed as Whole Time Director of the Company for a period of 3 years from March 06, 2025 to March 05, 2028 in the board meeting held on March 06, 2025 and confirmed by the members through (01/2025-26) postal ballot dated May 19, 2025.
3. Mr. Shubham Chaudhary (DIN: 09298013) was appointed as Whole Time Director of the Company for a period of 3 years from March 06, 2025 to March 05, 2028 in the board meeting held on March 06, 2025 and confirmed by the members through (01/2025-26) postal ballot dated May 19, 2025.
4. Mr. Saurabh (DIN: 10790325) was appointed as a Non-Executive Independent Director of the Company for a period of 5 years from March 06, 2025 to March 05, 2030 in the board meeting held on March 06, 2025 and confirmed by the members through (01/2025-26) postal ballot dated May 19, 2025.
5. Ms. Bhawna Saunkhiya (DIN: 10683032) was appointed as a Non-Executive Independent Director of the Company for a period of 5 years from April 04 2025 to April 03, 2030 in the board meeting held on April 04, 2025 and confirmed by the members through (01/2025-26) postal ballot dated May 19, 2025.
6. Ms. Shruti Gupta (DIN: 10310259) was appointed as a Non-Executive Independent Director of the Company for a period of 5 years from April 04 2025 to April 03, 2030 in the board meeting held on April 04, 2025 and confirmed by the members through (01/2025-26) postal ballot dated May 19, 2025.
7. Ms. Abha Rajesh Kapoor (DIN: 02799429) resigned from the position of Whole-Time Director and Chief Financial Officer of the Company with effect from September 16, 2025.
8. Mr. Shubham Chaudhary (DIN: 09298013) was appointed as Chief Financial Officer of the Company with effect from September 17, 2025.
9. Mr. Gopal Kumar Sahu (DIN: 08478039) resigned as Non-Executive Independent Director of the Company with effect from November 10, 2025, due to personal reasons.
10. Mr. Pradeep Kumar (DIN: 00209355) resigned as Whole-Time Director of the Company with effect from December 3, 2025, due to personal reasons.
11. Re-designation of Mr. Shubham Chaudhary (DIN: 09298013) from Whole-Time Director and Chief Financial Officer to Managing Director and Chief Financial Officer, in the board meeting held on December 3, 2025 and confirmed by the members through (03/2025-26) postal ballot dated January 19, 2026.
12. Appointment of Mr. Anubhav Kumar Upadhyay (DIN: 09519842) as Whole-Time Director for a period of three years in the board meeting held on December 3, 2025 and confirmed by the members through (03/2025-26) postal ballot dated January 19, 2026.
13. Appointment of Mr. Gunjan Gangwal (DIN: 11413389) as Non-Executive Independent Director is confirmed by the members through (03/2025-26) postal ballot dated January 19, 2026.
14. Resignation of Ms. Bhawna Saunkhiya (DIN: 10683032) as Non-Executive Independent Director w.e.f. March 18, 2026.
15. Resignation of Mr. Saurabh (DIN: 10790325) as Non-Executive Independent Director w.e.f. March 18, 2026.
16. Appointment of Mr. Ashish Jain (DIN: 11613144) as Additional Non-Executive Independent Director for a period of five years, subject to approval of the members w.e.f. March 18, 2026.
17. Appointment of Mr. Gaurav Kaushik (DIN: 11613118) as Additional Non-Executive Independent Director for a period of five years, subject to approval of the members w.e.f. March 18, 2026.
Subsequent to the year under review, the following changes were made to the
composition of the Board of Directors:
1. Appointment of Mr. Ashish Jain (DIN: 11613144) as Non-Executive Independent Director for a period of five years w.e.f. March 18, 2026 and confirmed by the members through (01/2026-27) postal ballot dated June 18, 2026.
2. Appointment of Mr. Gaurav Kaushik (DIN: 11613118) as Non-Executive Independent Director for a period of five years w.e.f. March 18, 2026 and confirmed by the members through (01/2026-27) postal ballot dated June 18, 2026.
3. Mr. Kumar Anubhav Upadhyay (Din: 09519842) resigned as Whole-Time Director of the Company, w.e.f. May 26, 2026
4. Ms. Shruti Gupta (DIN: 10310259) resigned as Non-Executive Independent Director of the Company, w.e.f. July 13, 2026
22. DETAILS OF SUBSIDIARIES/ASSOCIATES/JOINT VENTURES, IF ANY:
As on March 31, 2026, the Company does not have any subsidiary, associate or joint venture.
23. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION & FOREIGN EXCHANGE
EARNINGS AND OUTGO
The information pertaining to Conservation of Energy, Technology Absorption and
Foreign Exchange earnings and outgo as required under section 134(3)(m) of the
Companies Act, 2013 read with rule 8(3) of the Companies (Accounts) Rules, 2014 is annexed to this report as Annexure II.
24. VIGIL MEGHANISM
The Company has established a Vigil Mechanism that enables the Directors and Employees to report genuine concerns. The Vigil Mechanism provides for
(a) adequate safeguards against victimization of persons who use the Vigil Mechanism; and
(b) direct access to the Chairperson of the Audit Committee of the Board of Directors of the Company in appropriate or exceptional cases.
The web link for the policy is as under:
https://www.rubramed.com/policies/Vigil-Mechanism-Policy.pdf
25. CORPORATE SOCIAL RESPONSIBILITY
The provisions of Corporate Social Responsibility are not applicable to the Company as it does not fall within the purview of Section 135(1) of the Companies Act, 2013.
26. RELATED PARTY TRANSACTIONS
There were no contracts or arrangements entered into by the Company with related parties referred to in sub-section (1) of section 188 of the Companies Act, 2013. The related party transactions as per IND AS 24 are given in the notes to the financial accounts and forms part of the Annual Report.
The policy on Related Party Transactions is part of the website of the Company. The web link for the policy on related party transaction is as under: https://www.rubramed.com/policies/Related-Party-Transaction.pdf
27. RISK MANAGEMENT
The Company has devised and implemented a mechanism for risk management.
28. FAMILIARIZATION PROGRAMME FOR INDEPENDENT DIRECTORS
The Company proactively keeps its directors informed of the activities of the Company, its management and operations and provides an overall industry perspective as well as issues being faced by the industry. Details of the Familiarization program for Independent Directors form part of the website of the Company. The web link of Familiarization program is as under:
https://www.rubramed.com/policies/Familarisation-of-Independent-Director.pdf
29. MEETING OF BOARD OF DIRECTORS
The details of Board Meeting forms part of Corporate Governance Report.
30. CORPORATE GOVERNANCE
As per the provisions of Regulation 17 to 27 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, to the extent possible. A separate section on Corporate Governance forms part of the Directors Report as stipulated in Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, is included in the Annual Report as Annexure IV.
31. MANAGEMENT DISCUSSION AND ANALYSIS REPORT
Management discussion and analysis report is annexed as Annexure V .
32. STATEMENT OF COMPLIANCE OF APPLICABLE SECRETARIAL STANDARDS:
The Board hereby states that the Company has complied with all the applicable secretarial standards to the extent possible.
33. INDEPENDENT DIRECTORS MEETING
The Board of Directors of the Company meets once in every Financial Year without the presence of Executive Directors and Management of the Company. The role of the Directors is as per the provisions of Companies Act, 2013 as well as the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
34. DECLARATION BY INDEPENDENT DIRECTOR
Pursuant to Section 149(6) of the Companies Act, 2013 and SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, the Independent Directors of the Company have given the declaration to the Company that they qualify the criteria of independence as required under the Act.
35. BOARD EVALUATION
Pursuant to the provisions of Companies Act, 2013 and SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, the Board has carried out annual performance evaluation of its own performance, the directors individually as well the evaluation of the working of its Audit, Nomination & Remuneration and Stakeholder committee, including the Chairman of the Board who were evaluated on parameters such as level of engagement and contribution and independence of judgment thereby safeguarding the interest of the Company. The performance evaluation of the Independent Directors was carried out by the entire Board. The performance evaluation of the Chairman and the Non-Independent Directors was carried out by the Independent Directors. The Directors expressed their satisfaction with the evaluation process.
36. PARTICULARS OF LOANS GIVEN, GUARANTEES GIVEN OR INVESTMENTS MADE UNDER SECTION 186 OF COMPANIES ACT, 2013
Particulars of loans, guarantees and investments made by Company pursuant to Section 186 of the Companies Act, 2013 are given in the notes to the financial accounts forming part of the Annual Report. The loans and advances made by the Company, during the financial year under review, are within the limits prescribed in the section 186 of the Companies Act, 2013.
37. MATERIAL CHANGES BETWEEN THE DATE OF THE BOARD REPORT AND END OF FINANCIAL YEAR
Subsequent to year under review, no material changes were made between the date of the board report and end of financial year.
38. MATERIAL DEVELOPMENTS DURING THE FINANCIAL YEAR
Material changes subsequent to the end of the financial year is disclosed herein above.
39. SIGNIFICANT AND / OR MATERIAL ORDERS PASSED BY THE REGULATORS
No significant and/or material order was passed by any Regulator, any Court in India or any Tribunal, impacting the going concern status and the Companys operations in future.
40. THE DETAILS OF APPLICATION MADE OR ANY PROCEEDING PENDING UNDER THE INSOLVENCY AND BANKRUPTCY CODE, 2016 (31 OF 2016) DURING THE YEAR ALONGWITH THEIR STATUS AS AT THE END OF THE FINANCIAL YEAR
As on March 31, 2026, there is no proceeding pending under the Insolvency and Bankruptcy Code, 2016.
41. THE DETAILS OF DIFFERENCE BETWEEN AMOUNT OF THE VALUATION DONE AT THE TIME OF ONE TIME SETTLEMENT AND THE VALUATION DONE WHILE TAKING LOAN FROM THE BANKS OR FINANCIAL INSTITUTIONS ALONG WITH THE REASONS THEREOF
There is no one time settlement done with bank or any financial institution.
42. IN CASE THE SECURITIES ARE SUSPENDED FROM TRADING, THE DIRECTORS REPORT SHALL EXPLAIN THE REASON THEREOF
The trading of the company has not been suspended.
43. NOMINATION AND REMUNERATION POLICY
An extract of the Companys policy relating to directors appointment, payment of remuneration and discharge of their duties is annexed herewith. The web link to the Nomination and Remuneration Policy is as under:
https://www.rubramed.com/policies/NominationandRemunerationPolicy.pdf
44. PARTICULARS OF EMPLOYEES AND RELATED DISCLOSURES
The Company does not have any employee/Director who is in receipt of remuneration exceeding the sum prescribed in Section 197 of the Companies Act, 2013 (the Act)
read with Rule 5 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014.
In terms of the provisions of Section 197(12) of the Act read with Rules 5(2) and 5(3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, a statement showing the names of the top ten employees in terms of remuneration drawn and names and other particulars of the employees drawing remuneration in excess of the limits set out in the said rules is available for inspection.
Having regard to the second proviso to rule 5(3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, such particulars shall be made available to any shareholder on a specific request made by him in writing before the date of such Annual General Meeting. Any member interested in obtaining such information may write to the company. The same is annexed herewith as Annexure- IV.
45. A STATEMENT REGARDING OPINION OF THE BOARD WITH REGARD TO INTEGRITY, EXPERTISE AND EXPERIENCE (INCLUDING THE PROFICIENCY) OF THE INDEPENDENT DIRECTORS APPOINTED DURING THE YEAR
In the opinion of the board, the independent directors fulfill the conditions specified in SEBI (LODR) Regulations, 2015, and are independent of the management of the Company. The Independent Directors have complied with the code prescribed in schedule IV of the Companies Act, 2013.
46. DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013
The company has in place a policy for prevention of sexual harassment in accordance with the requirements of the Sexual Harassment of women at workplace (Prevention, Prohibition & Redressal) Act, 2013. Internal Complaints Committee has been set up to redress complaints received regarding sexual harassment.
The Board thereafter constituted a sexual harassment committee. The Composition of sexual harassment Committee as on March 31, 2026 is as under:
| Name of the Member | Status |
| Ms. Shruti Gupta - Non-Executive Independent Director | Chairperson |
| Ms. Bhawna Saunkhiya - Non-Executive Independent Director | Member |
| Mr. Saurabh - Non-Executive Independent Director | Member |
Mr. Saurabh (DIN: 10790325) and Ms. Bhawna Saunkhiya (DIN: 10683032), NonExecutive Independent director of the Company has resigned from the Directorship of the Company w.e.f. March 18, 2026.
Hence the Sexual Harassment Committee of the Company is re-constituted w.e.f. March 18, 2026.
The Revised Composition of Sexual Harassment Committee is as under:
| Name of the Member | Status |
| Shruti Gupta - Non-Executive Independent Director | Chairperson |
| Gunjan Gangwal - Non-Executive Independent Director | Member |
| Ashish Jain- Non-Executive Independent Director | Member |
All employees (permanent, contractual, temporary, trainees) are covered under this policy.
a. number of complaints filed during the financial year - None
b. number of complaints disposed of during the financial year - None
c. number of complaints pending as on end of the financial year - None
47. TRANSFER OF AMOUNTS TO INVESTOR EDUCATION AND PROTECTION FUND
The Company does not have any funds lying unpaid or unclaimed for a period of seven years. Therefore, there were no funds which were required to be transferred to Investor Education and Protection Fund (IEPF).
48. MATERNITY BENEFIT
The Company affirms that it has duly complied with all provisions of the Maternity Benefit Act, 1961, and has extended all statutory benefits to eligible women employees during the year.
49. ADEQUACY OF INTERNAL FINANCIAL CONTROLS
The Company has adequate internal financial controls besides timely statutory audit and limited reviews of performance taking place periodically.
50. REGISTRATION WITH INDEPENDENT DIRECTORS DATABANK
The Independent directors of the company are registered with independent director databank.
51. DIRECTORS RESPONSIBILITY STATEMENT
Pursuant to Section 134 of the Act, the Directors state that:
(a) In the preparation of the annual accounts, the applicable accounting standards have been followed along with proper explanation relating to material departures, if any;
(b) Appropriate accounting policies have been selected and applied consistently and have made judgments and estimates that are reasonable and prudent, so as to give a true and fair view of the state of affairs of the Company as at March 31, 2026 and of the profit for the Company for the year ended March 31, 2026;
(c) Proper and sufficient care has been taken for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 2013 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;
(d) The annual accounts have been prepared on a going concern basis;
(e) Proper internal financial controls were followed by the Company and such internal financial controls are adequate and were operating effectively;
(f) Proper systems are devised to ensure compliance with the provisions of all applicable laws and that such systems are adequate and operating effectively.
52. ACKNOWLEDGEMENT
Your Directors takes opportunity to show gratitude towards the assistance and cooperation received from Shareholders.
For and on Behalf of the Board of Directors of Centuple Global Limited (Formerly known as Checkpoint Trends Limited)
| Sd/- | Sd/- | |
| Gunjan Gangwal | Shubham Chaudhary | |
| Place: Nashik | Director | Whole time Director |
| Date: September 05, 2026 | DIN:11413389 | DIN: 09298013 |
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.